JF
LRMR icon

Jump Financial’s Larimar Therapeutics LRMR Stock Holding History

Jump Financial’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$414K Sell
135,601
-164,099
-55% -$652K ﹤0.01% 1538
2026
Q1 		$1.35M Buy
299,700
+203,626
+212% +$814K 0.02% 809
2025
Q4 		$366K Buy
+96,074
New +$374K ﹤0.01% 1452
2025
Q2 		– Sell
-86,350
Closed -$186K – 2002
2025
Q1 		$186K Sell
86,350
-21,194
-20% -$67K ﹤0.01% 1445
2024
Q4 		$416K Buy
107,544
+12,893
+14% +$85.1K 0.01% 1166
2024
Q3 		$620K Buy
94,651
+49,002
+107% +$394K 0.01% 1018
2024
Q2 		$331K Sell
45,649
-32,556
-42% -$249K 0.01% 1337
2024
Q1 		$594K Buy
+78,205
New +$609K 0.02% 1075
2023
Q3 		– Sell
-11,700
Closed -$36.6K – 2086
2023
Q2 		$36.6K Sell
11,700
-4,500
-28% -$18.4K ﹤0.01% 1736
2023
Q1 		$73.4K Buy
+16,200
New +$84.6K ﹤0.01% 1477

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Jump Financial's LRMR Position: Q2 2026 in Review

Jump Financial reduced its Larimar Therapeutics (LRMR) stake by 55% in Q2 2026, selling an estimated $652K and leaving 135,601 shares worth $414K. The position accounts for ﹤0.01% of the portfolio, ranked #1538.

Jump Financial first reported a position in LRMR in Q1 2023 and has held it in 10 quarters since. The position peaked at $1.35M in Q1 2026. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Jump Financial held 135,601 shares of Larimar Therapeutics worth $414K as of Q2 2026.
  • Jump Financial sold 164,099 Larimar Therapeutics shares in Q2 2026, an estimated $652K.
  • Larimar Therapeutics made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1538 holding.
  • Jump Financial first reported a position in Larimar Therapeutics in Q1 2023 and has held it in 10 quarters since.
  • Jump Financial's Larimar Therapeutics position peaked at $1.35M in Q1 2026.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.